This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pomerantsev, A. P. Articles by Leppla, S. H. Search for Related Content PubMed PubMed Citation Articles by Pomerantsev, A. P. Articles by Leppla, S. H.

 Previous Article  |  Next Article 

Infection and Immunity, January 2006, p. 682-693, Vol. 74, No. 1
0019-9567/06/$08.00+0     doi:10.1128/IAI.74.1.682-693.2006

Genome Engineering in Bacillus anthracis Using Cre Recombinase

Andrei P. Pomerantsev, Ramakrishnan Sitaraman, Craig R. Galloway, Violetta Kivovich, and Stephen H. Leppla^*

Bacterial Toxins and Therapeutics Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-4349

Received 8 August 2005/ Returned for modification 22 September 2005/ Accepted 13 October 2005

Genome engineering is a powerful method for the study of bacterial virulence. With the availability of the complete genomic sequence of Bacillus anthracis, it is now possible to inactivate or delete selected genes of interest. However, many current methods for disrupting or deleting more than one gene require use of multiple antibiotic resistance determinants. In this report we used an approach that temporarily inserts an antibiotic resistance marker into a selected region of the genome and subsequently removes it, leaving the target region (a single gene or a larger genomic segment) permanently mutated. For this purpose, a spectinomycin resistance cassette flanked by bacteriophage P1 loxP sites oriented as direct repeats was inserted within a selected gene. After identification of strains having the spectinomycin cassette inserted by a double-crossover event, a thermo-sensitive plasmid expressing Cre recombinase was introduced at the permissive temperature. Cre recombinase action at the loxP sites excised the spectinomycin marker, leaving a single loxP site within the targeted gene or genomic segment. The Cre-expressing plasmid was then removed by growth at the restrictive temperature. The procedure could then be repeated to mutate additional genes. In this way, we sequentially mutated two pairs of genes: pepM and spo0A, and mcrB and mrr. Furthermore, loxP sites introduced at distant genes could be recombined by Cre recombinase to cause deletion of large intervening regions. In this way, we deleted the capBCAD region of the pXO2 plasmid and the entire 30 kb of chromosomal DNA between the mcrB and mrr genes, and in the latter case we found that the 32 intervening open reading frames were not essential to growth.

Present address: Department of Medicine, Division of Gastroenterology, Vanderbilt University, Nashville, TN 37232.

Editor: J. D. Clements

This article has been cited by other articles:

• Kubler-Kielb, J., Vinogradov, E., Hu, H., Leppla, S. H., Robbins, J. B., Schneerson, R. (2008). Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component. Proc. Natl. Acad. Sci. USA 105: 8709-8712 [Abstract] [Full Text]  
• Banerjee, A., Biswas, I. (2008). Markerless Multiple-Gene-Deletion System for Streptococcus mutans. Appl. Environ. Microbiol. 74: 2037-2042 [Abstract] [Full Text]  
• Leibig, M., Krismer, B., Kolb, M., Friede, A., Gotz, F., Bertram, R. (2008). Marker Removal in Staphylococci via Cre Recombinase and Different lox Sites. Appl. Environ. Microbiol. 74: 1316-1323 [Abstract] [Full Text]